Many
neurological and psychiatric disorders with predominantly cerebral cortical
pathology, including most severe strokes, traumatic brain injuries, malignant
brain tumors, intractable focal epilepsies and dementias such as Alzheimer’sdisease are currently difficult, if not impossible, to treat. This causes
suffering in almost 100 million people worldwide.
We propose that bioengineered
cranial bones with multiple intelligent functions, including sitespecific
transmeningeal drug delivery and neurotoxin drainage with EEG feedback, can
provide effective treatment of these brain disorders by drug combinations that
act on both synapses and genes with concomitant selective drainage of harmful
extracellular molecules. After examining and summarizing the rationale andfeasibility of this proposal, we suggest novel methods for extending the
functions of the involved components including synergies with existing devices
and we highlight relevant preclinical results, discussing medical prospects of
this novel neurotherapeutic approach. Finally, we discuss key engineering,
scientific, clinical and ethical challenges to introducing bioengineered
cranial bones with multiple intelligent functions to the clinic within a decade.
No comments:
Post a Comment